Compare Abeona Therapeutics Inc (ABEO) vs Heron Therapeutics Inc (HRTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Abeona Therapeutics Inc vs Heron Therapeutics Inc — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Heron Therapeutics Inc trades at $0.32 (market cap $61.47M). The key difference: Abeona Therapeutics Inc is far larger — about 6.9× Heron Therapeutics Inc's market cap, and Abeona Therapeutics Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals.
| ABEO | HRTX | |
|---|---|---|
Market Cap | $421.19M | $61.47M |
Sector | Health | Health |
52-Week High | $7.45 | $1.49 |
52-Week Low | $4.17 | $0.32 |
Enterprise Value | $276.10M | $168.21M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →
